Recording: Biosimilars for Inflammatory Diseases: Why we all should care? (requires an aah.org email address to view)

Topic: Biosimilars for Inflammatory Diseases: Why we all should care? 

Overview: This webinar will discuss the use of biosimilars for inflammatory diseases. The main focus will be on adalimumab for its various indications

Speaker:
Alvin Wells, MD, PhD, FACR, FACP
Director, Department of Rheumatology, AAMG-WI 
Assistant Clinical Professor, Medical College of WI

Moderator:
Ashley Kwasinski, DNP, APNP
Nurse Practitioner, Infectious Disease

Objectives:
At the completion of this activity, the participant should be able to:

  • Define a biosimilar medication
  • Discuss the development and approval process for a biosimilar medication
  • Discuss the implications of changing from an originator product to a biosimilar
  • Review current clinical data on the use of biosimilar medications
Session date: 
03/16/2023 - 7:00am to 8:00am CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
    Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
    Attendance Credit

Please login or register to take this course.